Insulin resistance is the major factor that precipitates type 2 diabetes mellitus (T2DM) in high-income countries 1 . T2DM occurs when β-cells are no longer able to maintain the degree of hyperinsulinaemia necessary to overcome insulin resistance. Central obesity, measured by waist circumference, is an excellent marker of insulin resistance 1 . In Africa, T2DM from β-cell insufficiency might be common 2 . As T2DM related predominantly to β-cell failure is unrelated to adiposity, and only minimally affected by insulin resistance 3 , waist circumference will not be able to identify T2DM risk from this cause.
The relative importance of insulin resistance versus β-cell function in the development of T2DM varies by geography, income, culture, early-life nutritional and environmental exposures and genetics [2] [3] [4] . This difference in aetiology raises the possibility that the efficacy of clinical parameters used to predict T2DM risk could vary across the globe. The focus of this commentary is on the relationship of waist circumference to T2DM risk in people of African descent.
The aetiological relationships between T2DM, insulin resistance and central obesity were first recognized in high-income countries and assumed to be uniformly applicable to populations worldwide 1 . Therefore, we first describe the insights gained about waist circumference as a risk factor for T2DM from high-income countries. We then focus on the challenge of establishing waist circumference thresholds to predict T2DM in low-income areas of the world, particularly Africa, where the T2DM epidemic began decades later than in Europe or the USA and where β-cell insufficiency might be the dominant causal factor 2,3 .
T2DM in high-income countries
In the high-income countries of Europe and North America, the T2DM epidemic began in the 20th century and is closely linked to increases in obesity, particularly central obesity 1 . Visceral adiposity promotes insulin resistance and clinically manifests as central obesity 1 . As waist circumference is a marker of visceral adiposity, waist circumference is considered in both clinical care settings and epidemiological investigations to be an inexpensive, easily obtainable anthropometric measure of insulin resistance 1 .
Waist circumference is part of the metabolic syndrome. The metabolic syndrome, which has been widely studied in Europe and North America, was codified in 1988 and has five parameters: waist circumference (specific to the sex and race and/or ethnicity), blood pressure (systolic ≥130 mmHg and/or diastolic ≥85 mmHg), triglyceride levels (≥150 mg/dl), HDL-cholesterol levels (men <40 mg/dl and women <50 mg/dl) and fasting plasma levels of glucose (≥100 mg/dl). Each parameter was chosen because of a direct and independent relationship to insulin resistance. The metabolic syndrome is diagnosed if any three of the five parameters are present 1 . Clinically, if a patient is diagnosed with the metabolic syndrome, insulin resistance is considered to be present 1 . In population studies from Europe and North America, the metabolic syndrome has been shown to be associated with a fivefold increase in risk of T2DM and a twofold increased risk of heart disease 1,2 .
It is important to appreciate that neither waist circumference nor the metabolic syndrome are diagnostic tests for T2DM; they are risk factors for the future development of T2DM.
T2DM in individuals from Africa
Central obesity contributes to the 21st century epidemic of T2DM on the continent of Africa 2,5 ; however, emerging data suggests that β-cell insufficiency, independent of obesity and insulin resistance, also contributes to the high prevalence of T2DM in low-and middle-income countries [2] [3] [4] . Adebowale A. Adeyemo and colleagues 4 performed a genome-wide association study in 5,231 individuals from Nigeria, Ghana and Kenya and found that ZRANB3 is an African-specific locus for T2DM that is associated with β-cell mass and insulin response. From a clinical perspective, J. Damas Kabakambira and colleagues 2 assessed glucose tolerance status, insulin resistance, β-cell secretion and visceral fat mass in African-born individuals living in the USA. It was found that ~20% of the participants had abnormal The relationship between type 2 diabetes mellitus (T2DM), insulin resistance and central obesity is not uniformly applicable to populations worldwide. In this Comment, we discuss the challenge of establishing waist circumference thresholds to predict T2DM in Africa. In short, studies need to be designed to determine the degree to which β-cell insufficiency without insulin resistance leads to T2DM in individuals from African countries. Even if β-cell insufficiency is responsible for only a fraction of the cases of T2DM in Africa, it is likely to be a sizeable fraction 2 . Most importantly, central obesity, assessed by waist circumference, cannot be used as a predictor for a disease for which it is not a risk factor (such as T2DM secondary to β-cell insufficiency).
Waist circumference thresholds
International health-care organizations have identified waist circumference thresholds that predict insulin resistance by sex and race and/or ethnicity 1 . There are two major challenges associated with identifying waist circumference thresholds of risk for individuals from Africa. First, there is a lack of data on the waist circumference that predicts insulin resistance in individuals from Africa. Second, the continuum between waist circumference, insulin resistance and T2DM could be difficult to delineate if there is no way to distinguish T2DM caused predominantly by insulin resistance versus primarily β-cell insufficiency.
Insulin resistance and central obesity
In 2008, the WHO stated that the data from Africa was insufficient and that they would make no recommendations on the waist circumference threshold that should be used to predict either insulin resistance or risk for T2DM in men and women from Africa 2 . However, since 2008, many investigations have been conducted in Africa that leveraged the metabolic syndrome data to determine the waist circumference of risk. As each parameter for the metabolic syndrome is associated with insulin resistance, investigators decided that the simultaneous presence of any two parameters could be used to identify the waist circumference threshold associated with insulin resistance 2, 5 . Studies that used the metabolic syndrome parameters to identify the waist circumference to predict insulin resistance in individuals from Africa can be divided into two categories: the first excludes individuals with previously diagnosed T2DM 2 ; and the second includes individuals with previously diagnosed T2DM 5 .
In studies in which individuals from Africa with previously diagnosed T2DM were excluded, the waist circumference that predicted insulin resistance in men ranged between 80 cm and 85 cm and in women between 90 cm and 99 cm (REF. 2 ). Support for this result can be found in a computerized tomographic study of visceral adipose tissue volume and insulin resistance in African-born men and women living in the USA 2 .
By contrast, in a large meta-analysis in which individuals from Africa with previously diagnosed T2DM were included, the waist circumference that predicted insulin resistance was much lower: ~81 cm for men and women 5 . The challenge with these studies is that there was no way to distinguish between the individuals who had T2DM because of β-cell failure versus insulin resistance. Waist circumference is lower when T2DM is due to β-cell failure, but there is minimal or no insulin resistance.
The fact that both types of T2DM occur in individuals from Africa is well illustrated by examining abdominal computerized tomographic scans from two men born in Rwanda and living in the USA (Fig. 1) . FiguRE 1a is an abdominal computerized tomographic image from a 45-year-old man with newly diagnosed T2DM, who has a BMI of 22.2 kg/m 2 , low waist circumference, low visceral adiposity and primarily β-cell insufficiency, whereas Fig. 1b is an image from a 49-year-old man with newly diagnosed T2DM who has a BMI of 28.9 kg/m 2 , high waist circumference, high visceral adiposity and insulin resistance.
In short, when individuals from Africa with T2DM without insulin resistance are included in the calculation for waist circumference to identify insulin resistance, the waist circumference thresholds used to identify individuals at risk will be spuriously low. An important way forward might be to redo the meta-analyses described by Kenneth Ekoru and colleagues 5 and exclude individuals from Africa with T2DM and then determine the waist circumference that predicts insulin resistance. If the fraction of individuals from Africa with T2DM from β-cell failure are artefactually lowering the waist circumference associated with insulin resistance, on re-analysis the waist circumference that predicts insulin resistance will be increased.
Conclusion
Waist circumference can predict risk for T2DM due to insulin resistance in individuals from Africa. However, waist circumference cannot be used to predict diseases for which central obesity is not a risk factor, such as T2DM from predominantly β-cell insufficiency.
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